August 10, 2022
Features
1
8
The clinical trial research environment has evolved because of specific solutions designed to overcome uncertainty.
August 10, 2022
Features
1
8
Preclinical testing is better able to evaluate complex drug candidates thanks to innovations in animal model approaches.
August 05, 2022
News
1
8
La Jolla’s acquisition of Carterra’s LSA Platform is designed to advance their immunological and infectious disease research.
August 04, 2022
New Technology
1
8
Synthego has launched new engineered cell libraries to validate targets for quicker drug discovery timelines.
August 02, 2022
New Technology
1
8
Bio-Rad has expanded its range of recombinant monoclonal anti-idiotypic antibodies.
July 27, 2022
New Technology
1
8
Shimadzu’s new ultra-high performance liquid chromatography system is designed to solve common problems in biopharma analysis.
July 27, 2022
New Technology
1
8
Roche’s new test is the first available immunoassay that allows for simultaneous, independent determination of the hepatitis C virus antigen and antibody status.
July 26, 2022
News
1
8
Discovery Life Sciences’ acquisition of AllCells is intended to bolster its cell and gene therapy products and services.
July 19, 2022
New Technology
1
8
The PerkinElmer Flow Cytometry Instrument Concierge Services will provide biopharmaceutical labs with expert, on-site flow cytometry specialists.
July 13, 2022
News
1
8
Merck, known as MSD outside the United States and Canada, now offers the Merck Digital Sciences Studio, designed to enable innovative tech for drug discovery and development.
July 13, 2022
News
1
8
Pfizer and Touchlight have signed a patent license agreement for Pfizer to use Touchlight’s doggybone DNA (dbDNA) in the manufacture of mRNA vaccines, therapeutics, and gene therapies.